Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase
Science · 15.05.2025 · 388 (6748)
DOI: 10.1126/science.adt5199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 15.05.2025. Verfasst von Isaac P Witte und 14 weiteren Autor:innen. Beteiligte Einrichtung: Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA. Hauptthemen laut MEDLINE: Transposases, CRISPR-Cas Systems, Directed Molecular Evolution, Gene Editing. Die Arbeit wurde bisher 126-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Howard Hughes Medical Institute, NIBIB NIH HHS.
Abstract (Originalsprache)
Programmable gene integration in human cells has the potential to enable mutation-agnostic treatments for loss-of-function genetic diseases and facilitate many applications in the life sciences. CRISPR-associated transposases (CASTs) catalyze RNA-guided DNA integration but thus far demonstrate minimal activity in human cells. Using phage-assisted continuous evolution (PACE), we generated CAST variants with >200-fold average improved integration activity. The evolved CAST system (evoCAST) achieves ~10 to 30% integration efficiencies of kilobase-size DNA cargoes in human cells across 14 tested genomic target sites, including safe harbor loci, sites used for immunotherapy, and genes implicated in loss-of-function diseases, with undetected indels and low levels of off-target integration. Collectively, our findings establish a platform for the laboratory evolution of CASTs and advance a versatile system for programmable gene integration in living systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
- Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
- Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA.
- Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA.
- Howard Hughes Medical Institute, Columbia University, New York, NY, USA.
- Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN, USA.
ORCID-Profile: Isaac P Witte, George D Lampe, Simon Eitzinger, Shannon M Miller, Kiara N Berríos, Rebeca T King, Olivia G Stringham, Phuc Leo H Vo, Albert T Chen, Jakub Tolar, Mark J Osborn, Samuel H Sternberg, David R Liu
Förderung
- NIGMS NIH HHS
- Howard Hughes Medical Institute
- NIBIB NIH HHS
- NHGRI NIH HHS
- NCI NIH HHS
- NHLBI NIH HHS
- NIAMS NIH HHS
Zitieren
APA
Witte, I. P., Lampe, G. D., Eitzinger, S., Miller, S. M., Berríos, K. N., McElroy, A. N., King, R. T., Stringham, O. G., Gelsinger, D. R., Vo, P. L. H., Chen, A. T., Tolar, J., Osborn, M. J., Sternberg, S. H., & Liu, D. R. (2025). Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase. Science, 388(6748). https://doi.org/10.1126/science.adt5199
Vancouver
Witte IP, Lampe GD, Eitzinger S, Miller SM, Berríos KN, McElroy AN, et al. Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase. Science. 2025;388(6748). doi:10.1126/science.adt5199
BibTeX
@article{Witte2025,
author = {Witte, Isaac P and Lampe, George D and Eitzinger, Simon and Miller, Shannon M and Berríos, Kiara N and McElroy, Amber N and King, Rebeca T and Stringham, Olivia G and Gelsinger, Diego R and Vo, Phuc Leo H and Chen, Albert T and Tolar, Jakub and Osborn, Mark J and Sternberg, Samuel H and Liu, David R},
title = {Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase},
journal = {Science},
year = {2025},
volume = {388},
number = {6748},
doi = {10.1126/science.adt5199}
}
EUVIMED